GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001) von Slomovitz, Brian, Deng, Wei, Killion, Josh, Weroha, S. John, Backes, Floor, Miller, David, Tenney, Meaghan, Vogel, Tilley Jenkins, Chen, Lee-may, Markham, Merry, Chon, Hye Sook, Coleman, Robert, Gershenson, David

Volltext

Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial von DiSilvestro, Paul, Banerjee, Susana, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William, Mathews, Cara, Liu, Joyce, McNamara, John, Lowe, Elizabeth S, Ah-See, Mei-Lin, Moore, Kathleen N

Volltext

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39) von Moore, Kathleen N, Bookman, Michael, Sehouli, Jalid, Miller, Austin, Anderson, Charles, Scambia, Giovanni, Myers, Tashanna, Taskiran, Cagatay, Robison, Katina, Mäenpää, Johanna, Willmott, Lyndsay, Colombo, Nicoletta, Thomes-Pepin, Jessica, Liontos, Michalis, Gold, Michael A, Garcia, Yolanda, Sharma, Sudarshan K, Darus, Christopher J, Aghajanian, Carol, Okamoto, Aikou, Wu, Xiaohua, Safin, Rustem, Wu, Fan, Molinero, Luciana, Maiya, Vidya, Khor, Victor K, Lin, Yvonne G, Pignata, Sandro

Volltext

Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis von Levinson, Kimberly, Beavis, Anna L., Purdy, Christopher, Rositch, Anne F., Viswanathan, Akila, Wolfson, Aaron H., Kelly, Michael G., Tewari, Krishnansu S., McNally, Leah, Guntupalli, Saketh R., Ragab, Omar, Lee, Yi-Chun, Miller, David S., Huh, Warner K., Wilkinson, Kelly J., Spirtos, Nicola M., Van Le, Linda, Casablanca, Yovanni, Holman, Laura L., Waggoner, Steven E., Fader, Amanda N.

Volltext

The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation von Monk, Bradley J., Coleman, Robert L., Herzog, Thomas J., Moore, Kathleen N., O'Malley, David M., Randall, Leslie M., Slomovitz, Brian M., Eskander, Ramez, Pothuri, Bhavana, Reese, Laura L., Mannel, Robert S., Copeland, Larry J.

Volltext

GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function von Carter, Jeanne, Huang, Helen Q., Armer, Jane, Carlson, Jay W., Lockwood, Suzy, Nolte, Susan, Kauderer, James, Hutson, Alan, Walker, Joan L., Fleury, Aimee C., Bonebrake, Albert, Soper, John T., Mathews, Cara, Zivanovic, Oliver, Richards, William Edward, Tan, Annie, Alberts, David S., Barakat, Richard R., Wenzel, Lari B.

Volltext

GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patients von Carlson, Jay W., Kauderer, James, Hutson, Alan, Carter, Jeanne, Armer, Jane, Lockwood, Suzy, Nolte, Susan, Stewart, Bob R., Wenzel, Lari, Walker, Joan, Fleury, Aimee, Bonebrake, Albert, Soper, John, Mathews, Cara, Zivanovic, Oliver, Richards, Wm Edward, Tan, Annie, Alberts, David S., Barakat, Richard R.

Volltext

Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial von Banerjee, Susana, Moore, Kathleen N, Colombo, Nicoletta, Scambia, Giovanni, Kim, Byoung-Gie, Oaknin, Ana, Friedlander, Michael, Lisyanskaya, Alla, Floquet, Anne, Leary, Alexandra, Sonke, Gabe S, Gourley, Charlie, Oza, Amit, González-Martín, Antonio, Aghajanian, Carol, Bradley, William H, Holmes, Eileen, Lowe, Elizabeth S, DiSilvestro, Paul

Volltext

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial von Gershenson, David M, Miller, Austin, Brady, William E, Paul, James, Carty, Karen, Rodgers, William, Millan, David, Coleman, Robert L, Moore, Kathleen N, Banerjee, Susana, Connolly, Kate, Secord, Angeles Alvarez, O'Malley, David M, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robert L, Herrington, C Simon, Huang, Helen Q, Wenzel, Lari, Gourley, Charlie

Volltext

An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer von Cosgrove, Casey M., Tritchler, David L., Cohn, David E., Mutch, David G., Rush, Craig M., Lankes, Heather A., Creasman, William T., Miller, David S., Ramirez, Nilsa C., Geller, Melissa A., Powell, Matthew A., Backes, Floor J., Landrum, Lisa M., Timmers, Cynthia, Suarez, Adrian A., Zaino, Richard J., Pearl, Michael L., DiSilvestro, Paul A., Lele, Shashikant B., Goodfellow, Paul J.

Volltext

Minority participation in Gynecologic Oncology Group (GOG) Studies von Scalici, Jennifer, Finan, Michael A, Black, Jennifer, Harmon, Mary Danner, Nicolson, William, Lankes, Heather A, Brady, William E, Rocconi, Rodney P

Volltext

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study von Norquist, Barbara M, Brady, Mark F, Harrell, Maria I, Walsh, Tom, Lee, Ming K, Gulsuner, Suleyman, Bernards, Sarah S, Casadei, Silvia, Burger, Robert A, Tewari, Krishnansu S, Backes, Floor, Mannel, Robert S, Glaser, Gretchen, Bailey, Cheryl, Rubin, Stephen, Soper, John, Lankes, Heather A, Ramirez, Nilsa C, King, Mary Claire, Birrer, Michael J, Swisher, Elizabeth M

Volltext

Long Term Survival of GOG 252 ‘Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/GOG Study’ (021) von Walker, Joan, Mark, Brady, Moore, Kathleen, Tewari, Krishnansu, Thaker, Premal, DiSilvestro, Paul, Le, Linda Van, Guntupalli, Saketh, Gray, Heidi, Rose, Peter, Alberts, David, Fujiwara, Keiichi, Mannel, Robert, Aghajanian, Carol, Copeland, Larry, Fleming, Gini

Volltext

Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer – An NRG/GOG study von Chan, John K., Tian, Chunqiao, Kesterson, Joshua P., Lin, Ken Y., Darcy, Kathleen, Richardson, Michael T., Kapp, Daniel S., Monk, Bradley J., McNally, Leah, Landrum, Lisa, Copeland, Larry, Walker, Joan L., Wenham, Robert M., Phippen, Neil, Spirtos, Nick M., Tewari, Krishnansu, Shahin, Mark, Berry, Laurel, Bell, Jeffery G.

Volltext

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE) von Carter, Jeanne, Huang, Helen Q., Armer, Jane, Carlson, Jay W., Lockwood, Suzy, Nolte, Susan, Stewart, Bob R., Kauderer, James, Hutson, Alan, Walker, Joan L., Fleury, Aimee C., Bonebrake, Albert, Soper, John T., Mathews, Cara, Zivanovic, Oliver, Richards, William Edwards, Tan, Annie, Alberts, David S., Barakat, Richard R., Wenzel, Lari

Volltext

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182 von Horowitz, Neil S, Miller, Austin, Rungruang, Bunja, Richard, Scott D, Rodriguez, Noah, Bookman, Michael A, Hamilton, Chad A, Krivak, Thomas C, Maxwell, G Larry

Volltext

Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial von Gee, Michael S, Atri, Mostafa, Bandos, Andriy I, Mannel, Robert S, Gold, Michael A, Lee, Susanna I

Volltext

Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study von Gillen, Jessica, Miller, Austin, Bell-McGuinn, Katherine M., Schilder, Russell J., Walker, Joan L., Mathews, Cara A., Duska, Linda R., Guntupalli, Saketh R., O'Cearbhaill, Roisin, Hays, John, Hagemann, Andrea R., Gray, Heidi J., Gordon, Sarah W., Armstrong, Deborah K., Chen, Alice, Fracasso, Paula M., Aghajanian, Carol, Moore, Kathleen N.

Volltext

Gog and GOGAm pentagons von Biane, Philippe, Cheballah, Hayat

Volltext

Structures, NMR Spectroscopic Features, and Cytotoxic Properties of Oligomeric Hellinoyl (m‑GO‑m‑GOG)-Type Ellagitannins from the Galls of Tamarix aphylla von Orabi, Mohamed A. A, Orabi, Esam A, Taniguchi, Shoko, Sakagami, Hiroshi, Yoshimura, Morio, Amakura, Yoshiaki, Hatano, Tsutomu

Volltext